Quest Diagnostics Inc vs Fortinet Inc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.23B), while Fortinet Inc trades at $160.72 (market cap $120.48B). The key difference: Fortinet Inc is far larger — about 4.6× Quest Diagnostics Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Fortinet Inc pays none. Which is the better fit depends on your goals.
| DGX | FTNT | |
|---|---|---|
Market Cap | $26.23B | $120.48B |
Sector | Health | Technology |
52-Week High | $238.50 | $168.29 |
52-Week Low | $173.49 | $75.23 |
Enterprise Value | $31.99B | $116.91B |
Dividend Yield | 1.45% | — |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Fortinet is a cybersecurity vendor that sells products, support, and services to small and midsize businesses, enterprises, and government entities. Its products include unified threat management appliances, firewalls, network security, and its security platform, Security Fabric. Services revenue is primarily from FortiGuard security subscriptions and FortiCare technical support. At the end of 2021, products were 38% of revenue and services were 62% of sales. The California-based company sells products worldwide.
Read more on FTNT →